LFCM
Long Focus Capital Management’s Insmed INSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.4M | Sell |
520,200
-110,600
| -18% | -$11.1M | 1.98% | 6 |
|
|
2025
Q1 | $48.1M | Sell |
630,800
-20,000
| -3% | -$1.53M | 1.61% | 6 |
|
|
2024
Q4 | $44.9M | Buy |
650,800
+21,900
| +3% | +$1.51M | 1.46% | 8 |
|
|
2024
Q3 | $45.9M | Sell |
628,900
-112,000
| -15% | -$8.18M | 1.61% | 7 |
|
|
2024
Q2 | $49.6M | Buy |
740,900
+309,251
| +72% | +$20.7M | 1.9% | 4 |
|
|
2024
Q1 | $11.7M | Buy |
431,649
+60,000
| +16% | +$1.63M | 0.6% | 26 |
|
|
2023
Q4 | $11.5M | Hold |
371,649
| – | – | 0.38% | 24 |
|
|
2023
Q3 | $9.38M | Hold |
371,649
| – | – | 0.34% | 26 |
|
|
2023
Q2 | $7.84M | Buy |
371,649
+10,000
| +3% | +$211K | 0.36% | 33 |
|
|
2023
Q1 | $6.17M | Buy |
361,649
+36,649
| +11% | +$625K | 0.35% | 37 |
|
|
2022
Q4 | $6.49M | Buy |
325,000
+55,000
| +20% | +$1.1M | 0.45% | 37 |
|
|
2022
Q3 | $5.82M | Buy |
270,000
+20,000
| +8% | +$431K | 0.57% | 31 |
|
|
2022
Q2 | $4.93M | Buy |
250,000
+90,000
| +56% | +$1.77M | 0.52% | 38 |
|
|
2022
Q1 | $3.76M | Buy |
160,000
+80,000
| +100% | +$1.88M | 0.48% | 42 |
|
|
2021
Q4 | $2.18M | Buy |
+80,000
| New | +$2.18M | 0.29% | 45 |
|